Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab: A Phase 2 Clinical Trial.
暂无分享，去创建一个
L. Qin | C. Antonescu | S. Singer | J. Erinjeri | C. Kelly | C. Ariyan | W. Tap | M. Gounder | M. Callahan | P. Chi | A. Crago | R. Munhoz | Sam S. Yoon | P. Wong | M. Dickson | M. Keohan | S. Movva | T. Bowler | E. Bartlett | Sinchun Hwang | S. D’Angelo | Matthew D Biniakewitz | Haley T Phelan | M. Condy | Reena Dholakia | Hamza Ahmad | Matthew D. Biniakewitz | Sam S. Yoon | Ping Chi